Edition:
United States

Cytori Therapeutics Inc (CYTX.OQ)

CYTX.OQ on NASDAQ Stock Exchange Capital Market

0.34USD
20 Aug 2018
Change (% chg)

-- (--)
Prev Close
$0.34
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
43,591
52-wk High
$8.70
52-wk Low
$0.31

Select another date:

Wed, May 23 2018

BRIEF-Cytori Therapeutics Common Stock To Begin Trading On Adjusted Basis On May 24

* CYTORI THERAPEUTIC’S COMMON STOCK TO BEGIN TRADING ON ADJUSTED BASIS ON MAY 24, FOLLOWING ONE-FOR-TEN REVERSE SPLIT Source text for Eikon: Further company coverage:

BRIEF-Cytori Reports Q1 2018 Business And Financial Results

* Q1 EARNINGS PER SHARE VIEW $-0.06 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Cytori Provides Update On U.S. Manufacturing And EU Approval Plans For ATI-0918, Liposomal Doxorubicin

* CYTORI PROVIDES UPDATE ON U.S. MANUFACTURING AND EU APPROVAL PLANS FOR ATI-0918, LIPOSOMAL DOXORUBICIN

BRIEF-Cytori Therapeutics - Co Met With U.S. FDA To Discuss Outcome Of Star Clinical Trial

* CYTORI THERAPEUTICS - ON MARCH 1, CO MET WITH U.S. FDA TO DISCUSS OUTCOME OF STAR CLINICAL TRIAL AND CO'S PLANS FOR HABEO CELL THERAPY - SEC FILING

BRIEF-Cytori Q4 Adjusted Loss Per Share $0.10

* CYTORI REPORTS FOURTH QUARTER AND FULL YEAR 2017 BUSINESS AND FINANCIAL RESULTS

Select another date: